Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cushman & Wakefield (CWK) EBITDA (2017 - 2025)

Cushman & Wakefield (CWK) has 9 years of EBITDA data on record, last reported at $176.9 million in Q4 2025.

  • For Q4 2025, EBITDA rose 1.38% year-over-year to $176.9 million; the TTM value through Dec 2025 reached $452.5 million, up 33.52%, while the annual FY2025 figure was $517.1 million, 24.54% up from the prior year.
  • EBITDA reached $176.9 million in Q4 2025 per CWK's latest filing, up from $107.5 million in the prior quarter.
  • Across five years, EBITDA topped out at $249.4 million in Q4 2021 and bottomed at -$18.3 million in Q1 2023.
  • Average EBITDA over 5 years is $101.5 million, with a median of $110.6 million recorded in 2022.
  • Peak YoY movement for EBITDA: soared 43533.33% in 2021, then tumbled 113.53% in 2023.
  • A 5-year view of EBITDA shows it stood at $249.4 million in 2021, then tumbled by 55.45% to $111.1 million in 2022, then dropped by 0.99% to $110.0 million in 2023, then surged by 58.64% to $174.5 million in 2024, then rose by 1.38% to $176.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were $176.9 million in Q4 2025, $107.5 million in Q3 2025, and $122.8 million in Q2 2025.